Literature DB >> 10357037

Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients.

P Rosel1, B Arranz, J Vallejo, P Alvarez, J M Menchon, T Palencia, M A Navarro.   

Abstract

BACKGROUND: Serotonergic system alterations were studied in 51 depressed patients classified according to DSM-III-R criteria for major depression with melancholia compared to 31 healthy controls.
METHOD: [3H]Imipramine and [3H]paroxetine binding sites and the 5HT2 receptor were simultaneously determined in blood platelet membranes.
RESULTS: A significantly lower maximum binding in [3H]imipramine binding was observed in depressed patients compared to controls (1134+/-74 vs. 1712+/-106 fmol/mg protein, P<0.0001) without changes in the equilibrium dissociation constant (1.10+0.05 vs. 1.25-/+0.09 nM). [3H]Paroxetine binding did not differ between the two groups (Bmax, 1441+/-55 vs. 1280+/-81 fmol/mg protein; Kd, 0.060+/-0.002 vs. 0.062+/-0.002 nM). The K(d) value of 5HT2 binding was lower in depressed patients than controls (0.95+/-0.04 vs. 1.15+/-0.09 nM, P<0.039) without changes in maximum binding (140+/-11 vs. 127+/-14 fmol/mg protein).
CONCLUSIONS: Taken together, these results suggest that [3H]imipramine and 5HT2 receptors may be good biological markers for serotonergic dysfunction in depressive disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357037     DOI: 10.1016/s0165-0327(98)00030-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.

Authors:  N M K Ng Ying Kin; Joel Paris; George Schwartz; Hallie Zweig-Frank; Howard Steiger; N P V Nair
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 2.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

3.  Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.

Authors:  J Roggenbach; B Müller-Oerlinghausen; L Franke; R Uebelhack; S Blank; B Ahrens
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

4.  Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects.

Authors:  Karley Y Little; Lian Zhang; Edwin Cook
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

5.  In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.

Authors:  Subhash M Nadgir; Manish Malviya
Journal:  Neurochem Res       Date:  2008-04-25       Impact factor: 3.996

6.  Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.

Authors:  Kimberly R Tyeryar; Ashiwel S Undie
Journal:  Psychopharmacology (Berl)       Date:  2007-04-15       Impact factor: 4.415

7.  Major depression during interferon-alpha treatment: vulnerability and prevention.

Authors:  Francis E Lotrich
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.